Converge Bio is at the of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs)
Total raised: $5.5M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.11.2024 | - | $5.5M | - |
Mentions in press and media 5
| Date | Title | Description |
| 22.11.2024 | Converge Bio: The Future of Drug Discovery Speaks the Language of Life | In the world of pharmaceuticals, time is a luxury few can afford. The process of drug discovery is a labyrinthine journey, often taking a decade or more, with costs spiraling past a billion dollars. Yet, a new player has entered the arena, ... |
| 22.11.2024 | Converge Bio raises $5.5M to expedite drug discovery, development with GenAI | Photo: mediaphotos/Getty Images Converge Bio has raised $5.5 million in seed funding led by TLV Partners. WHAT IT DOES Converge Bio is a generative AI hub for Biotech and Pharma that allows the accelerated discovery and development of drugs... |
| 21.11.2024 | Converge Bio Raises $5.5M to Accelerate Drug Discovery with GenAI | What You Should Know: – Converge Bio, a generative AI platform for accelerated drug discovery and development, today announced it has raised $5.5 million in seed funding, led by TLV Partners. – Converge Bio’s platform uses large language mo... |
| 20.11.2024 | Generative AI drug discovery hub Converge Bio raises $5.5M to understand the ‘language of biology’ Your vote of support is important to us and it helps us keep the content FREE. One click below suppor... | Drug discovery startup Converge Bio Inc. said today it has closed on a $5.5 million seed round of funding to help biotech and pharmaceutical companies develop more effective drugs at faster speeds by leveraging generative artificial intelli... |
| - | Converge Bio | “Converge Bio is at the of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLM... |